Ocular Therapeutix Inc. buy Royal Bank of Canada
Start price
06.05.26
/
50%
€8.25
Target price
06.05.27
€25.60
Performance (%)
-9.70%
Price
28.07.26
€7.45
Summary
This prediction is currently active. With a performance of -9.70%, the BUY prediction for Ocular Therapeutix Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 06.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -5.096% | -5.096% |
| iShares Core DAX® | 1,72 % | 3,37 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % |
| iShares S&P 500 | -0,89 % | 1,69 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix (OCUL) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $30.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€8.21
05.02.26
05.02.26
-
05.02.27
05.02.27
-9.26%
28.07.26
28.07.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.41
05.11.25
05.11.25
-
05.11.26
05.11.26
-20.80%
28.07.26
28.07.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€6.81
18.03.25
18.03.25
€15.58
18.03.26
18.03.26
7.64%
19.03.26
19.03.26